Tags

Type your tag names separated by a space and hit enter

The pathophysiology of migraine: implications for clinical management.
Lancet Neurol. 2018 Feb; 17(2):174-182.LN

Abstract

The understanding of migraine pathophysiology is advancing rapidly. Improved characterisation and diagnosis of its clinical features have led to the view of migraine as a complex, variable disorder of nervous system function rather than simply a vascular headache. Recent studies have provided important new insights into its genetic causes, anatomical and physiological features, and pharmacological mechanisms. The identification of new migraine-associated genes, the visualisation of brain regions that are activated at the earliest stages of a migraine attack, a greater appreciation of the potential role of the cervical nerves, and the recognition of the crucial role for neuropeptides are among the advances that have led to novel targets for migraine therapy. Future management of migraine will have the capacity to tailor treatments based on the distinct mechanisms of migraine that affect individual patients.

Authors+Show Affiliations

UCLA Goldberg Migraine Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: acharles@ucla.edu.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

29229375

Citation

Charles, Andrew. "The Pathophysiology of Migraine: Implications for Clinical Management." The Lancet. Neurology, vol. 17, no. 2, 2018, pp. 174-182.
Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174-182.
Charles, A. (2018). The pathophysiology of migraine: implications for clinical management. The Lancet. Neurology, 17(2), 174-182. https://doi.org/10.1016/S1474-4422(17)30435-0
Charles A. The Pathophysiology of Migraine: Implications for Clinical Management. Lancet Neurol. 2018;17(2):174-182. PubMed PMID: 29229375.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The pathophysiology of migraine: implications for clinical management. A1 - Charles,Andrew, Y1 - 2017/12/08/ PY - 2017/4/9/received PY - 2017/9/22/revised PY - 2017/9/25/accepted PY - 2017/12/13/pubmed PY - 2019/1/25/medline PY - 2017/12/13/entrez SP - 174 EP - 182 JF - The Lancet. Neurology JO - Lancet Neurol VL - 17 IS - 2 N2 - The understanding of migraine pathophysiology is advancing rapidly. Improved characterisation and diagnosis of its clinical features have led to the view of migraine as a complex, variable disorder of nervous system function rather than simply a vascular headache. Recent studies have provided important new insights into its genetic causes, anatomical and physiological features, and pharmacological mechanisms. The identification of new migraine-associated genes, the visualisation of brain regions that are activated at the earliest stages of a migraine attack, a greater appreciation of the potential role of the cervical nerves, and the recognition of the crucial role for neuropeptides are among the advances that have led to novel targets for migraine therapy. Future management of migraine will have the capacity to tailor treatments based on the distinct mechanisms of migraine that affect individual patients. SN - 1474-4465 UR - https://www.unboundmedicine.com/medline/citation/29229375/full_citation DB - PRIME DP - Unbound Medicine ER -